Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2002-04-12
2008-09-09
McGarry, Sean (Department: 1635)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S023100, C536S024300, C536S024330, C536S024500
Reexamination Certificate
active
07423022
ABSTRACT:
The present invention provides DNAzymes and ribozymes that specifically cleave Hairless Protein mRNA. The present invention also provides antisense oligonucleotides that specifically inhibit translation of Hairless Protein mRNA. The invention also provides various methods of inhibiting the expression of Hairless Protein. Finally the invention provides pharmaceutical compositions containing the instant DNAzymes, ribozymes and antisense oligonucleotides as active ingredients.
REFERENCES:
patent: 6348348 (2002-02-01), Thompson
patent: WO9938965 (1999-08-01), None
Cichon et al. Cloning, genomic organization, alternative transcripts and mutational analysis of the gene responsible for autosomal recessive universal congenital alopecia. Human Molecular Genetics, 1998 vol. 7:1671-1679.
Panteleyev et al. Molecular and functional aspects of the hairless gene in laboratory rodents and humans. Experimental Dermatology, 1998 vol. 7:249-267.
Branch, A. A Good Antisense is Hard to Find. TIBS, Feb. 1998 vol. 23, pp. 45-50.
Jen et al. Suppression of Gene Expression by Targeted Disruption of Messenger RNA: Available Options and Current Strategies. Stem Cells, 2000, vol. 18:307-319.
Ahmad et al. Genomic Organization of the Human Hairless Gene and Identification of a Mutation Underlying Congenital Atrichia inan Arab Palestinian Family. Genomics, 1999 vol. 55:1-9.
Santoro et al. A general purpose RNA-cleaving DNA enzyme. Proceedings of the National Academy of Sciences, 1997 vol. 94:4262-4266.
Milligan et al. Current Concepts in Antisense Drug Design. Journal of Medicinal Chemistry, 1993 vol. 36:1923-1937.
Weintraub, HM. Antisense RNA and DNA. Scientific American, 1990 pp. 40-46.
Cserhalmi-Friedman et al. Recapitulation of the hairless mouse phenotype using catalytic oligonucleotides: implications for permanent hair removal. Experimental Dermatology, 2004 vol. 13:155-162.
Dokka et al., J Invest Dermatol., 2005 vol. 124:971-975.
Nielsen, PE. Systemic delivery: The last hurdle? Gene Therapy, 2005 vol. 12:956-957.
Sun et al. Catalytic Nucleic Acids: From Lab to Applications. Pharmacol Rev., 2000 vol. 52:325-347.
Ahmad, Wasim et al. (1999) Genomic Organization of the Human Hairless Gene (HR) and Identification of a Mutation Underlying Congenital Atrichia in an Arab Palestinian Family,Genomics55: (2):141-148.
Sprecher, Eli et al. (1998) Atrichia With Papular Lesions Maps to 8p in the Region Containing the Human Hairless Gene,American Journal of Medical Genetics80: 546-550.
Santorio, Stephen W. et al. (1997) A general purpose RNA-cleaving DNA enzyme,Proc. Natl. Acad. Sci. USA94: 4262-4266.
Ahmad, Wasim et al. (1998) Alopecia Universalis Associated with a Mutation in the Human hairless Gene,Science279: 720-724.
Cichon, Sven et al. (1998) Cloning, genomic organization, alternative transcripts and mutational analysis of the gene responsible for autosomal recessive universal congenital alopecia,Human Molecular Genetics7: 1671-1679.
Cserhalmi-Friedman et al. (2004) Experimental Dermatology 13(3):155-162 Recapitulation of the hairless mouse phenotype using catalytic oligonucleotides: implications for permanent hair removal.
Cairns et al. (2000) Nucleic acid mutation analysis using catalytic DNA. Nucleic Acids Res 28:E9.
Fedor M.J. (2000) Structure and Function of the Hairpin Ribozyme. J. Mol. Biol. 297 (2):269-91.
Jen et al. (2000) Suppression of Gene Expression by Targeted Disruption of Messenger RNA:Available Options and Current Strategies. Stem Cells 18:307-319.
Santoro et al. (2000) RNA cleavage by a DNA enzyme with extended chemical functionality. J. Am. Chem. Soc. 122(11):2433-9.
Bartel D.P. (1999) Creation and evolution of new ribozymes. Biol. Bull. 196:322-3.
Long and Sullenger (1999) Evaluating group I intron catalytic efficiency in mammalian cells. Mol. Cell. Biol. 19: 6479-87.
Parthasarathy et al. (1999) Hammerhead ribozyme-mediated inactivation of mutant RET in medullary thyroid carcinoma. Cancer Res. 59:3911-4.
Santiago et al. (1999) New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury. Nat. Med. 5(11):1264-1268. Nat. Med. 5(11):1264-69. Erratum 5(12):1438.
Ahmad et al. (1998) Molecular basis of a novel rhino (hr(rhChr)) phenotype: a nonsense mutation in the mouse hairless gene. Exp. Dermatol. 7:298-301.
Branch A. (1998) A Good Antisense is Hard to Find. Trends Biochem. Sci. 23:45-50.
Panteleyev et al. (1998) Molecular and functional aspects of the hairless (hr) gene in laboratory rodents and humans. Exp. Dermatol. 7:249-67.
Panteleyev et al. (1998) Molecular basis for the rhino Yurlovo (hr (rhY) ) phenotype:severe skin abnormalities and female reproductive defects associated with an insertion in the hairless gene. Exp. Dermatol. 7:281-8.
Phylactou et al. (1998) Ribozymes as therapeutic tools for genetic disease. Human Mol. Genet. 7:(10) 1649-53.
Santoro and Joyce (1998) Mechanism and utility of an RNA-cleaving DNA enzyme. Biochemistry 37:13330-42.
Vaish et al. (1998) Recent developments in the hammerhead ribozyme field. Nucleic Acids Res. 26:5237-42.
Bertrand et al. (1997) The expression cassette determines the functional activity of ribozymes in mammalian cells by controlling their intracellular localization. RNA 3:75-88.
Montgomery and Dietz (1997) Inhibition of fibrillin 1 expression using U1 snRNA as a vehicle for the presentation of antisense targeting sequence. Hum. Mol. Genet. 6:519-25.
Flory et al. (1996) Nuclease resistant ribozymes decrease stromelysin mRNA levels in rabbit synovium following exogenous delivery to the knee joint. Proc. Natl. Acad. Sci. USA 93:754-758.
Matzura and Wennborg (1996) RNAdraw: an integrated program for RNA secondary structure calculation and analysis under 32-bit Microsoft Windows. Comput. Appl. Biosci. 12:247-9.
Michienzi et al. (1996) U1 small nuclear RNA chimeric ribozymes with substrate specificity for the Rev pre -mRNA of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 93:7219-7224.
Sioud M. (1996) Ribozyme modulation of lipopolysaccharide induced tumor necrosis factor-alpha production by peritoneal cells in vitro and in vivo. Eur. J. Immunol. 26:30 1026-1031.
Pley et al. (1994) Three-dimensional structure of a hammerhead ribozyme. Nature 372:68-74.
Sioud and Drlica (1991) Prevention of human immunodeficiency virus type 1 integrase expression inEscherichia coliby a ribozyme. Proc. Natl. Acad. Sci. USA 88: 7303-7.
Cech T.R. (1987) The chemistry of self-splicing RNA and RNA enzymes. Science 236:1532-9.
Baker & Botts L.L.P.
Gibbs Terra Cotta
McGarry Sean
The Trustees of Columbia University in the City of New York
LandOfFree
Nucleic acids for inhibiting hairless protein expression and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleic acids for inhibiting hairless protein expression and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acids for inhibiting hairless protein expression and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3974781